Follow-up to COVID-19 transmission in schools study release

News

Posted on

We would like to address some of the feedback we’ve received regarding the COVID-19 in schools study, the results of which suggest that the risk of school staff acquiring SARS-CoV-2 in schools is no greater than those who don’t work in schools. We wrote about this study based on a story that originally appeared on the COVID-19 Immunity Task Force’s website.

First, we would like to acknowledge how hard the COVID-19 pandemic has been for everyone — but especially for teachers and other classroom-based staff.

As we mentioned in an article about the study on March 4, 2021, the main question guiding this research has been: Are teachers and other school staff being impacted during the COVID-19 pandemic in ways we don’t know or can’t yet see? The intent of the study was to use sensitive serological (antibody) testing to identify whether school-based contact tracing was potentially missing any “silent” asymptomatic transmission.

The researchers began by seeking to determine the extent of silent SARS-CoV-2 transmission in the school environment, in a study that was one of three studies across Canada funded by the COVID-19 Immunity Task Force, with the other two in Quebec and Ontario.

It was always the intent, as much as resources allowed, to add more school districts to the B.C. study. The research team reached out to various school districts in addition to Vancouver — including in the Fraser Valley, Delta and Richmond. Vancouver, Delta and Richmond are the school districts that have signed on to date, and Vancouver was the first to report, given that it was the first to participate.

To assess the level of SARS-CoV-2 infection among Vancouver School District staff, participants were compared, when possible, with control groups from the community where they lived — matched by the first two digits of their postal code. For example, if a teacher worked in a Vancouver school but lived in White Rock, then they were matched to a person in White Rock of a similar age.

We would like to reiterate that these are preliminary findings, as the study is in pre-print ahead of peer review. Given the conversations around decisions being made about the upcoming school year, the researchers felt it was appropriate to share the data at an early stage.

In addition to looking at transmission rates in schools, the researchers also investigated the mental health of teachers and school staff. The results from this part of the study should be available soon.

Do you have a question about this article or other BCCHR news?

Contact BCCHR Research Communications.

Kristen Hovet
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • children playing outdoors
    News

    Billions of doses later, global review confirms mRNA vaccines are safe

    A sweeping global review research has found that mRNA vaccines are safe and highly effective at preventing infectious diseases, such as COVID-19. These vaccines also have potential applications for a range of other diseases, including influenza, respiratory syncytial virus (RSV), cancer, and autoimmune disorders.

    Read more
  • Young child holding their head
    News

    Emerging treatment options offer hope to children affected by migraine

    Headache disorders, such as migraine, can drastically disrupt daily life. Still, they are underestimated, underrecognized, and undertreated. Migraine is among the top three causes of disability in individuals aged 10 to 24, with 10 per cent of children experiencing it before reaching puberty. Migraine is associated with school absenteeism, disengagement from extracurricular activities, and decreased…

    Read more
  • News

    Gut fungi may hold the key to treating asthma, allergies worldwide

    Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may be promising targets for new therapies.

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now